This protocol is judged by an institutional evaluation board, an independent team that opinions any scientific trials involving individuals. If a review will involve a Routine I drug, as soon as the board approves the protocol as ethical, the researchers should submit an application for an investigational new drug (IND) quantity within the FDA.Ple